Gain Therapeutics, Inc. (GANX)
Pharmaceutical Preparations
Latest Price
$1.68
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.33
P/B Ratio
5.06
Institutional Ownership
18.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 1.77M | $3.0M | 4.17% | +107.5K | 2026-03-31 |
| Potomac Capital Management, Inc. | 1.01M | $1.0M | 2.37% | -1.4K | 2026-03-31 |
| JONES FINANCIAL COMPANIES LLLP | 631.6K | $1.0M | 1.49% | -70.6K | 2026-03-31 |
| Cambridge Investment Research Advisors, Inc. | 568.6K | $1.0M | 1.34% | -- | 2026-03-31 |
| DME Capital Management, LP | 566.1K | $1.0M | 1.33% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 447.3K | -- | 1.05% | +49.4K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 399.9K | -- | 0.94% | -- | 2026-03-31 |
| GSA CAPITAL PARTNERS LLP | 312.5K | -- | 0.74% | +292.0K | 2026-03-31 |
| JANE STREET GROUP, LLC | 255.5K | -- | 0.60% | +13.2K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 230.0K | -- | 0.54% | -- | 2026-03-31 |